cannabis news Archives - Page 21 of 32 - The Real Dirt with Chip Baker

Skittles Manufacturer Sues Cannabis Brands for Trademark Infringement

by The Real Dirt | May 27, 2021 | 420 News, Blog, Business, Cannabis Law, Cannabis Law and Compliance, Legalization

Skittles is suing Zkittles cannabis brands

Skittles-maker Mars Wrigley has filed lawsuits against cannabis companies in Illinois, California, and Canada for trademark infringement.

New Jersey-based candy maker, Mars Wrigley, is suing cannabis companies in Illinois, California, and Canada to stop them from using its brand names and marketing for infused edibles, the Chicago Sun-Times reports. The lawsuit, filed in federal court, accuses the companies of infringing on the Starburst and Skittles candy brands, Ganjapreneur reports.

Mars Wrigley strongly condemns the use of popular candy brands in the marketing and sale of THC products, which is grossly deceptive and irresponsible. The use of Mars Wrigley’s brands in this manner is unauthorized, inappropriate and must cease, especially to protect children from mistakenly ingesting these unlawful THC products. – Mars Wrigley in a statement via the Sun-Times

The lawsuit names Terphogz and five companies that sell a cannabis strain and related products called Zkittlez, the report says. The unnamed defendants are “unknown” to Mars Wrigley but they are accused of purchasing the goods in question to resell to Illinois customers.

The California lawsuit targets products called “Medicated Skittles,” “Life Savers Medicated Gummies,” and “Starburst Gummies” – marketed by GasBuds – which appear to mimic the packaging of the popular, non-cannabis, confections.

The legal actions are the latest against cannabis companies for trademark infringement of popular consumer products.

Atlanta, Georgia-based Edible Arrangements in September sued Chicago’s Green Thumb Industries for using their brand name in their Incredible product, according to the Sun-Times. Two months later, Ferrera Candy Co. sued California-based Tops Cannabis over its “Medicated Nerds Rope.”

Other lawsuits have brought over the “Woodstock” brand; the logo of a Massachusetts lumber company; the Citibank name, parodied as “Citidank;” the Tapatio hot sauce name and logo; the Gorilla Glue brand; and the logo of the National Hockey League’s Toronto Maple Leafs, among others.

Mars Wrigley is seeking $2 million for each counterfeit trademark named in the California lawsuit, along with attorneys’ fees and costs in both cases.

Read Original Story from Ganjapreneur

DEA may allow companies to grow cannabis for scientific research

by The Real Dirt | May 19, 2021 | 420 News, Blog, Business, Cannabis Law, Growing, Hemp Law, Legalization, Medical Marijuana, Politics

DEA cannabis may be getting better for scientists

After years of delay under the Trump administration, the federal government is preparing to award the first new licenses for cultivating cannabis for scientific research, giving U.S. marijuana operators a crack at entering a business that has been dominated by the University of Mississippi for more than 50 years.

The U.S. Drug Enforcement Administration late last week signaled it would award the licenses soon by issuing a “Memorandum of Agreement” (MOA) to “a number” of organizations that applied for the opportunity, according to an agency news release. The move will allow greater research into marijuana and its potential medicinal properties. That, in turn, could spur more doctors to recommend medical cannabis, which likely would boost sales.

“We expect to receive our registration number this afternoon,” said Dr. Steven Groff, founder of Groff North America in Red Lion, Pennsylvania, one of three entities that on Friday received an MOA from the DEA.

The recipients are supposed to review the MOAs and return them to the DEA with comments or suggestions. Groff already returned its MOA, and two other recipients told MJBizDaily they’d return their paperwork in the coming days or weeks.

Besides Groff, at least two other organizations confirmed they’d received an MOA:

Scottsdale Research Institute in Arizona.
Biopharmaceutical Research Co. (BRC) in Castroville, California.

A DEA spokesperson declined to answer if any other MOAs were issued. It’s also unclear when, or if, the DEA intends to issue more MOAs.

“This has the potential to create a renaissance of cannabis research for decades,” Dr. Sue Sisley, president of the Scottsdale Research Institute, said in a phone interview. Sisley, a longtime cannabis advocate, has been studying marijuana’s potential therapeutic benefits.

George Hodgin, the CEO of BRC, echoed Sisley, saying in a phone interview: “This is a massive regulatory step.”

Currently, the University of Mississippi, or Ole Miss, is the only institution in the United States with DEA permission to cultivate cannabis for federally approved research, having been awarded its license in 1968.

Critics complain that the cannabis grown there doesn’t reflect what’s being sold in the marketplace today.

To expand the number of entities with federal licenses for cultivating marijuana for research, the Obama administration announced an application process in its final year. Nearly 30 businesses, research institutes, universities and other entities applied.

Read Full Story on MJ Biz Daily

Marijuana industry expected to add $92 billion to US economy in 2021

by The Real Dirt | May 12, 2021 | 420 Culture & Travel, 420 News, Blog, Business, Cannabis Law and Compliance, Culture, Legalization, Medical Marijuana

Marijuana revenue is expected to surpass $90 billion in 2021

From jobs to tax revenue to commercial real estate, the marijuana industry has a large – and growing – impact on the broader economy in the United States.

The total U.S. economic impact from marijuana sales in 2021 is expected to reach $92 billion – up more than 30% from last year – and upwards of $160 billion in 2025, according to analysis from the newly published MJBizFactbook.

To measure the industry’s economic impact, MJBizDaily analyzed similar industries and applied a standard multiplier of 3.5 on projected recreational and medical marijuana retail sales.

The numbers are a best guess because the marijuana industry’s structure is somewhat unique because it encompasses agricultural, manufacturing and retail activity.

The economic impact of the marijuana industry is not the same as supply-chain revenues that are often used to estimate the “total size” of an industry.

Rather, the economic multiplier paints a picture of the impact the industry has on the broader economy.

In this case, for every $1 consumers and patients spend at retail locations, an additional $2.50 will be injected into the economy, much of it at the local level.

That impact comes directly from the day-to-day needs of workers in the cannabis industry, including spending on life’s necessities such as housing, transportation, entertainment and more.

Marijuana businesses, consumers and patients also pay hundreds of millions of dollars in state and local taxes that are used to fund state and local government activities, including schools and roads.

In addition, real estate receives a boost from new retail, manufacturing and agricultural businesses moving into an area or established companies expanding, increasing broader demand for commercial properties.

Cultivating and manufacturing marijuana can require large investments in equipment and technology that boost not only the local economy but also areas throughout the U.S.

The list goes on.

Using the same multiplier methodology can also offer insight into the local-dollar impact from sales of recreational and/or medical marijuana.

The economic impact will vary by state based on the size, maturity and type of market.

For example, as the largest market in the U.S., California’s marijuana industry is expected to pump close to $20 billion into the state’s economy in 2021.

No other state comes close to that amount.

But states such as Colorado, Illinois, Oregon and Washington will provide more than $10 billion each for their local economies in the coming years.

Expect the same for markets in densely populated states such as New Jersey and New York as they develop.

If we consider total population, some states benefit more than others.

Read Full Story on MJ Biz Daily

Feds Announce New Standard THC Dose for Cannabis Research

by The Real Dirt | May 11, 2021 | 420 News, Blog, Cannabis Law, Growing, Legalization, Politics

The National Institute on Drug Abuse (NIDA) announced on Friday it was setting the new standard THC dose for cannabis research at five milligrams, Marijuana Moment reports. The requirement took effect immediately.

Inconsistency in the measurement and reporting of THC exposure has been a major limitation in studies of cannabis use, making it difficult to compare findings among studies. A standardized measure of THC in cannabis products is necessary to advance research by providing greater comparability across studies of both its adverse effects and potential medical uses. — NIDA Notice of Information excerpt

NIDA said the five-milligram standard unit was selected following extensive stakeholder input, expert consultation, and a request for information from the general public.

In its notice, NIDA recognized that “the same quantity of THC may have different effects” depending on a number of variables, including the method of administration, other ingredients in the product, an individual’s genetic make-up and tolerance levels, and more. Additionally, the notice clarified that the newly standardized THC unit does not limit the quantity of THC permissible in cannabis research, only the way in which investigators must record and report their work.

While cannabis remains a Schedule 1 substance under federal law, research efforts are difficult but not completely blocked: a 20-year study by the University of Minnesota recently revealed that long-term cannabis use has little to no effects on cognitive abilities, while another recent study found cannabis use to be associated with increased rates of exercise and physical activity.

Original Story from Ganjapreneur

US to ban Backwoods, Swishers and other flavored blunt wraps

by The Real Dirt | May 7, 2021 | 420 Culture & Travel, 420 News, Blog, Cannabis Law, Cannabis Law and Compliance, Legalization, Stranger Than Fiction

Your illegal weed dealer might be adding menthol cigarettes and smuggled Backwoods and Swisher Sweets to their offerings next year.

On Thursday, April 29, the Food and Drug Administration announced plans to ban menthol-flavored cigarettes and all flavored cigars, starting in 2022. The FDA’s proposal responds to a lawsuit from the African American Tobacco Control Leadership Council calling for the national ban, which would target makers and sellers, not users, of menthols and flavored cigars.

Tobacco companies will likely challenge the decision in court, according to Stat News.

But such a ban would affect many cannabis consumers—primarily Black smokers—who roll marijuana into flavored tobacco or cigar leaves, commonly called a blunt. Half of cigar sales in 2020 were two flavored brands: Black and Mild, followed by Swisher Sweets.

A 2020 study found that a third of weed consumers smoke blunts, while almost two-thirds of Black weed consumers smoke blunts. A separate study of blunt wrap brand Backwoods-tagged content on Instagram found that half of #backwoods posts were marijuana-related.

FDA confronts a health inequity

The FDA wants to reduce tobacco use, the leading cause of preventable death in the US. The agency stated that banning menthols and flavored cigars would reduce the number of kids who start smoking, and encourage menthol smokers to quit.

The FDA also said it specifically wants to reduce the number of Black Americans dying from tobacco. Three-quarters of Black smokers smoke menthols.

“Banning menthol—the last allowable flavor—in cigarettes and banning all flavors in cigars will help save lives, particularly among those disproportionately affected by these deadly products,” acting FDA Commissioner Janet Woodcock said in a statement.

Banning menthols may cause 923,000 US smokers to quit, including 230,000 Black Americans in the first 13 to 17 months after a ban goes into effect. An earlier study claims the ban would prevent 633,000 deaths, including about 237,000 deaths averted for African Americans.

To do that, massive tobacco companies and distributors would face punishment for making, distributing, and selling menthols and flavored tobacco no earlier than next year.